{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:43:53Z","timestamp":1779335033056,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research on the key Technologies of the creation and industrialization of New Special Chemical drugs for Animals","award":["2015BAD11B01-01"],"award-info":[{"award-number":["2015BAD11B01-01"]}]},{"name":"Drug Development and Clinical Drug use posts of National Beef Yak Industry Technical system","award":["CARS-37"],"award-info":[{"award-number":["CARS-37"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.yrtph.2019.01.012","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T05:01:41Z","timestamp":1547010101000},"page":"21-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Target animal safety testing of an oral salicylanilide suspension, oxyclozanide, for the treatment of fascioliasis in bovine in China"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2122-8541","authenticated-orcid":false,"given":"Zhen","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jichao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enliang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fugui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuzheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2019.01.012_bib1","series-title":"The Merck Veterinary Manual","author":"Aiello","year":"2016"},{"key":"10.1016\/j.yrtph.2019.01.012_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/vr.159.13.424","article-title":"Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain","volume":"159","author":"\u00c1lvarez-S\u00e1nchez","year":"2006","journal-title":"Vet. Rec."},{"issue":"2","key":"10.1016\/j.yrtph.2019.01.012_bib3","first-page":"149","article-title":"Cost benefits analysis of anthelmintic treatment of cattle and buffaloes","volume":"31","author":"Athar","year":"2011","journal-title":"Pak. Vet. J."},{"key":"10.1016\/j.yrtph.2019.01.012_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/pest.1995.1049","article-title":"Assessment of the developmental toxicity of in utero exposure of wistar albino rats to ametryne and niclosamide","volume":"53","author":"Awad","year":"1995","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.yrtph.2019.01.012_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/210744a0","article-title":"A new drug for the treatment of fascioliasis in sheep and cattle","volume":"210","author":"Broome","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.yrtph.2019.01.012_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ps.2780020307","article-title":"A possible biochemical mode of action of the fasciolicides nitroxynil, hexachlorophene and oxyclozanide","volume":"2","author":"Corbett","year":"2010","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.yrtph.2019.01.012_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/01926230490268756","article-title":"Best practices guideline: toxicologic histopathology","volume":"32","author":"Crissman","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2019.01.012_bib8","first-page":"53","article-title":"Comparative efficacy of triclabendazole, oxyclozanide and rafoxanide against fasciolopsis buski in naturally infected pigs","volume":"43","author":"Datta","year":"2004","journal-title":"Indian J. Anim. Health"},{"key":"10.1016\/j.yrtph.2019.01.012_bib9","series-title":"Committee For Medicinal Products for Veterinary Use Oxyclozanide (Extrapolation to all ruminants) Summary Report (3)","author":"European Medicines Agency (EMEA)","year":"2004"},{"key":"10.1016\/j.yrtph.2019.01.012_bib10","series-title":"Guideline for good clinical practice E6(R2)","author":"European Medicines Agency (EMEA)","year":"2015"},{"key":"10.1016\/j.yrtph.2019.01.012_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0021-9975(67)90025-4","article-title":"Activity of sorbitol dehydrogenase (S.D.) in the serum of sheep and cattle with liver damage","volume":"77","author":"Ford","year":"1967","journal-title":"J. Comp. Pathol."},{"issue":"3","key":"10.1016\/j.yrtph.2019.01.012_bib12","first-page":"58","article-title":"Target Animal Safety for Veterinary Pharmaceutical Products (VICH GL 43)","volume":"5","author":"Hahn","year":"2009","journal-title":"BVL-Reporte"},{"key":"10.1016\/j.yrtph.2019.01.012_bib13","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2527\/jas1979.4961464x","article-title":"Creatine phosphokinase isoenzymes in stress-susceptible and stress-resistant pigs","volume":"49","author":"Hallberg","year":"1979","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.yrtph.2019.01.012_bib14","series-title":"Fundamentals of Toxicologic Pathology","author":"Haschek","year":"2010"},{"key":"10.1016\/j.yrtph.2019.01.012_bib15","first-page":"1583","article-title":"Effect of oxyclozanide on feed efficiency in cattle with chronic fascioliasis","volume":"32","author":"Knapp","year":"1971","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.yrtph.2019.01.012_bib16","first-page":"311","article-title":"Target animal safety and tolerance study of pyrantel pamoate paste (19.13% w\/w pyrantel base) administered orally to horses","volume":"6","author":"Marchiondo","year":"2005","journal-title":"Vet THer"},{"key":"10.1016\/j.yrtph.2019.01.012_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tvjl.2008.01.002","article-title":"Efficacy of oxyclozanide against the rumen fluke Calicophoron daubneyi in experimentally infected goats","volume":"180","author":"Paraud","year":"2009","journal-title":"Vet. J."},{"key":"10.1016\/j.yrtph.2019.01.012_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF02356681","article-title":"Oxyclozanide\u2014Activity against fasciola gigantica in naturally infected buffalo, cattle, sheep and goats","volume":"3","author":"Roy","year":"1971","journal-title":"Trop. Anim. Health Prod."},{"key":"10.1016\/j.yrtph.2019.01.012_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1751-0813.1974.tb05305.x","article-title":"Sorbitol Dehydrogenase in the diagnosis of liver disease of ruminants","volume":"50","author":"Shaw","year":"2010","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.yrtph.2019.01.012_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1091581817711876","article-title":"Recommendations for Clinical Pathology Data Generation, Interpretation, and Reporting in Target Animal Safety Studies for Veterinary Drug Development","volume":"36","author":"Siska","year":"2017","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2019.01.012_bib21","first-page":"2485","article-title":"Effects of heat stress on endocrine hormone content, antioxidant enzyme activity and physiological and serum biochemical indices of beef cattle","volume":"24","author":"Song","year":"2012","journal-title":"Acta Zoonutrimenta Sin"},{"key":"10.1016\/j.yrtph.2019.01.012_bib22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/clinchem\/22.5.650","article-title":"Creatine kinase in serum: 1. Determination of optimum reaction conditions","volume":"22","author":"Szasz","year":"1976","journal-title":"Clin. Chem."},{"key":"10.1016\/j.yrtph.2019.01.012_bib23","series-title":"Product information database for Zanil Fluke Drench 34 mg\/ml Oral Suspension","author":"Veterinary Medicine Directorate (VMD)-GOV. UK","year":"2017"},{"key":"10.1016\/j.yrtph.2019.01.012_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/01480548508999164","article-title":"Toxicological properties of closantel","volume":"8","author":"Van","year":"1985","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2019.01.012_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1476-5381.1974.tb09622.x","article-title":"Uncoupling activity of the anthelmintic oxyclozanide in rodents","volume":"50","author":"Veenendaal","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.01.012_bib26","series-title":"Compilation of Technical guidelines for Veterinary Drug Research","author":"Veterinary Drug Assessment Center of the Ministry of Agriculture of the People\u2019s Republic of China","year":"2012"},{"key":"10.1016\/j.yrtph.2019.01.012_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/vr.78.8.267","article-title":"Oxyclozanide (3,3\u2019,5,5\u2019,6-pentachloro-2,2\u2019-dihydroxybenzanilide--6Zanil\") in the treatment of the liver fluke Fasciola hepatica in sheep and cattle","volume":"78","author":"Walley","year":"1966","journal-title":"Vet. Rec."},{"issue":"1","key":"10.1016\/j.yrtph.2019.01.012_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01267955","article-title":"Creatine kinase in non-muscle tissues and cells","volume":"133\u2013134","author":"Wallimann","year":"1994","journal-title":"Mol. Cell. Biochem."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019300121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019300121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T02:25:59Z","timestamp":1606011959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230019300121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":28,"alternative-id":["S0273230019300121"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.01.012","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Target animal safety testing of an oral salicylanilide suspension, oxyclozanide, for the treatment of fascioliasis in bovine in China","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}